Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seamus Fernandez
Pharma
Seasoned reps could help Aclaris' Eskata step on the gas
As Aclaris Therapeutics goes all-in on its Eskata launch, at least one analyst thinks the rollout could raise eyebrows among investors—in a good way.
Carly Helfand
Mar 26, 2018 9:35am
Settle down, Allergan investors. Botox's market share is safe
Dec 6, 2017 9:22am
Classwide growth boost could lift all new ovarian cancer meds
Nov 15, 2017 8:38am
Should Merck file anacetrapib with FDA? It's asking experts now
Jun 28, 2017 9:01am
Deal talk matches BMS with Pfizer, Roche or Novartis. Really?
Feb 15, 2017 10:53am
